2014 Drug Pricing Pharmaceutical Companies 
FDA Law Blog: Biosimilars
MARCH 18, 2025
Even though the PTE provisions established in the Drug Price Competition and Patent Restoration Act are forty-plus years old, courts are still grappling with questions about how to best implement the Patent Term Extension. The plain text of 35 U.S.C. The Court thus explained that interpreting the patent in 35 U.S.C.
pharmaphorum
JUNE 10, 2021
Jesse Mendelsohn explores pharma’s priorities on pricing, profits and progress post-Covid. It goes without saying that if pharmaceutical companies are not profitable, they will not survive. The truth about rising drug prices is more nuanced and merits exploration. The Big Misconception.
Expert insights. Personalized for you.
Let's personalize your content